Broadfin Capital, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 90 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.3%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$4,674,000
-56.0%
880,303
-68.2%
0.86%
-62.6%
Q2 2019$10,618,000
-64.5%
2,765,070
-52.8%
2.31%
-62.5%
Q1 2019$29,871,000
+148.2%
5,856,998
-6.6%
6.17%
+289.9%
Q4 2018$12,035,000
-38.0%
6,268,298
+22.0%
1.58%
-44.6%
Q3 2018$19,415,000
-8.1%
5,136,264
-24.2%
2.86%
-14.1%
Q2 2018$21,131,000
+29.8%
6,772,764
-0.6%
3.33%
+31.1%
Q1 2018$16,283,000
-41.3%
6,812,764
-4.0%
2.54%
-44.1%
Q4 2017$27,750,000
+59.8%
7,097,300
+3.0%
4.54%
+76.6%
Q3 2017$17,369,000
-14.4%
6,892,500
-6.2%
2.57%
+4.3%
Q2 2017$20,286,000
+26.9%
7,350,000
-10.4%
2.46%
+27.2%
Q1 2017$15,990,000
+85.7%
8,200,0000.0%1.94%
+102.6%
Q4 2016$8,610,000
-3.7%
8,200,0000.0%0.96%
+19.4%
Q3 2016$8,938,000
+53.5%
8,200,0000.0%0.80%
+41.5%
Q2 2016$5,822,000
-39.3%
8,200,0000.0%0.57%
-38.9%
Q1 2016$9,594,000
-6.4%
8,200,000
+96.0%
0.93%
+47.1%
Q4 2015$10,249,000
-18.3%
4,183,1770.0%0.63%
-9.7%
Q3 2015$12,550,000
-27.4%
4,183,1770.0%0.70%
-24.8%
Q2 2015$17,277,000
-2.3%
4,183,177
+2.4%
0.93%
-32.6%
Q1 2015$17,680,000
+24.0%
4,083,177
-14.9%
1.38%
+122.1%
Q4 2014$14,256,000
+206.7%
4,800,000
+242.9%
0.62%
+27.3%
Q3 2014$4,648,000
-61.7%
1,400,000
-70.8%
0.49%
-18.6%
Q2 2014$12,144,0004,800,0000.60%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 589,883$590,0001.38%
Broadfin Capital, LLC 8,200,000$8,610,0000.96%
Avoro Capital Advisors LLC 1,141,149$1,198,0000.24%
CORRADO ADVISORS, LLC 190,600$200,0000.12%
Baker Brothers Advisors 5,102,153$5,357,0000.05%
KINGDON CAPITAL MANAGEMENT, L.L.C. 756,311$794,0000.04%
Point72 Asset Management, L.P. 2,272,816$2,386,0000.02%
AGRAN LIBBIE 44,000$46,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 10,000$11,0000.01%
KENNEDY CAPITAL MANAGEMENT LLC 233,171$245,0000.00%
View complete list of CATALYST PHARMACEUTICALS INC shareholders